Related Headline News and Top Stories
Use of Chemotherapy plus a Monoclonal Antibody against HER2 for Metastatic Breast Cancer That Overexpresses HER2
Use of chemotherapy plus a monoclonal antibody against her2 for metastatic breast cancer that overexpresses her2 - 22-24 the results of this phase 3 clinical trial indicate that trastuzumab, when added to conventional chemotherapy, can benefit patients with metastatic breast cancer that overexpresses her2. as compared with the best available standard chemotherapy.
Recomended News to Read
USDAILY – MADISON, Wis. — The Wisconsin Supreme Court is set to rule on the 2011 law that effectively ended collective bargaining for most public workers, sparked massive protests and led to Gov. Scott Walker’s recall election. The court was scheduled to release its decision Thursday in a case challenging the constitutionality of the law. It […]
USDAILY – Since Florida’s frontier days when cattlemen drove their herds through the state’s vast fields and forests, ranchers and native panthers have been natural enemies. The ranchers seek to nurture and protect their calves, while the panthers see them as prey. Human development won the battle, driving the large, tawny, cats to the brink of […]